Table of Contents

company-logo

Prescient Therapeutics Limited, a clinical stage oncology company, develops novel drugs for the treatment of various cancers in Australia. Its lead drug candidate is PTX-200, which is in Phase 2a clinical trial for HER2-negative breast cancer, Phase IB/2 clinical trial in relapsed and refractory AML, and Phase 1b in recurrent or persistent platinum-resistant ovarian cancer; and PTX-100, a RhoA inhibitor, for hematological and solid malignancies that focuses on cancers with Ras and RhoA mutations. It has a strategic collaboration with The University of Texas MD Anderson Cancer Center to develop blood cancer binder for OmniCAR. The company was formerly known as Virax Holdings Limited and changed its name to Prescient Therapeutics Limited in December 2014. Prescient Therapeutics Limited was incorporated in 1986 and is based in Melbourne, Australia.

Prescient Therapeutics Dividend Announcement

• Prescient Therapeutics announced a annually dividend of A$0.04 per ordinary share which will be made payable on 1993-12-31. Ex dividend date: 1993-10-21
• Prescient Therapeutics's trailing twelve-month (TTM) dividend yield is -%

Prescient Therapeutics Dividend History

Ex-Div dateDividend amountDividend typePay date
1993-10-21A$0.04annually1993-12-31
1990-10-25A$0.03annually1991-01-25

Prescient Therapeutics Dividend per year

Prescient Therapeutics Dividend Yield

Prescient Therapeutics current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Prescient Therapeutics stock? Use our calculator to estimate your expected dividend yield:

Prescient Therapeutics Financial Ratios

P/E ratio-4.01
PEG ratio-0.04
P/B ratio1.83
ROE-40.50%
Payout ratio0.00%
Current ratio8.08
Quick ratio8.08
Cash Ratio4.52

Prescient Therapeutics Dividend FAQ

Does Prescient Therapeutics stock pay dividends?
Prescient Therapeutics does not currently pay dividends to its shareholders.
Has Prescient Therapeutics ever paid a dividend?
No, Prescient Therapeutics has no a history of paying dividends to its shareholders. Prescient Therapeutics is not known for its dividend payments.
Why doesn't Prescient Therapeutics pay dividends?
There are several potential reasons why Prescient Therapeutics would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Prescient Therapeutics ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Prescient Therapeutics has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Prescient Therapeutics a dividend aristocrat?
Prescient Therapeutics is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Prescient Therapeutics a dividend king?
Prescient Therapeutics is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Prescient Therapeutics a dividend stock?
No, Prescient Therapeutics is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Prescient Therapeutics stocks?
To buy Prescient Therapeutics you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Prescient Therapeutics stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.